Science & Enterprise subscription

Follow us on Twitter

  • Symptom checker K Health raises $48M https://t.co/hIEK1AL5vd
    about 17 hours ago
  • This makes me feel better ... Pence Will Control All Coronavirus Messaging From Health Officials https://t.co/M2Fv13okyE
    about 2 days ago
  • https://t.co/8n5kpVEGCH
    about 2 days ago
  • Takeda acquires PvP Biologics for $330M following Phase I celiac disease study results https://t.co/Amtm5sS9aq
    about 2 days ago
  • https://t.co/mZ8yGjsAgx Raises $462M With Toyota In The Driver’s Seat https://t.co/8gawjBxZzw via @crunchbasenews
    about 2 days ago

Please share Science & Enterprise

Intl Group Calls for More Coronavirus Vaccines

Hong Kong residents in masks

An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines

Infographic – Countries Where Coronavirus Reported

Research company Statista posted yesterday a map where coronavirus cases are confirmed, and number of cases as of 30 January. But the outbreak is spreading quickly. . . . → Read More: Infographic – Countries Where Coronavirus Reported

New Company Developing Cell-Based Milk

Milk splash

A biotechnology start-up enterprise plans to produce milk directly from mammary cells in the lab without crops, animals, or farms. . . . → Read More: New Company Developing Cell-Based Milk

Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

Global venture capital investing

Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

Synthetic Bio Cancer Immunotherapy Company Acquired

Natural killer cell

A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma. . . . → Read More: Synthetic Bio Cancer Immunotherapy Company Acquired

Engineered Organ Transplant Company Raises New Funds

Two piglets

An enterprise that applies gene editing to create replacement organs from pigs for human transplant is raising $100 million in new venture financing. . . . → Read More: Engineered Organ Transplant Company Raises New Funds

AstraZeneca Joins $1B Fund, Expands Footprint in China

Research lab in China

The pharmaceutical company AstraZeneca is starting a joint $1 billion health care investment fund in China and vastly increasing its labs and offices there. . . . → Read More: AstraZeneca Joins $1B Fund, Expands Footprint in China

Infographic – Govt Research Funds Fall Behind in U.S.

Government research spending

Funding for research at universities in the U.S. by government agencies is falling behind most other advanced countries, according to a new report. . . . → Read More: Infographic – Govt Research Funds Fall Behind in U.S.

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Laptops on a table

Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Deep Learning Techniques Speed Drug Discovery

Synthetic biology

Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs ready for validation and lab animal tests in 21 days. . . . → Read More: Deep Learning Techniques Speed Drug Discovery